Financials Goodness Growth Holdings, Inc.

Equities

GDNS

CA38238W1032

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:59:59 2024-04-26 pm EDT 5-day change 1st Jan Change
0.59 CAD +1.72% Intraday chart for Goodness Growth Holdings, Inc. +11.32% +87.30%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 90.51 144.4 218.9 20.32 34.41 61.69
Enterprise Value (EV) 1 90.51 144.4 218.9 20.32 34.41 61.69
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue 3.02 x 2.93 x 4.02 x 0.27 x 0.39 x 0.61 x
EV / Revenue 3.02 x 2.93 x 4.02 x 0.27 x 0.39 x 0.61 x
EV / EBITDA -5.43 x -27.6 x -24.2 x 4.94 x 1.62 x 2.6 x
EV / FCF -3,001,968 x -7,449,379 x -4,506,859 x - - -
FCF Yield -0% -0% -0% - - -
Price to Book - - - - - -
Nbr of stocks (in thousands) 85,253 98,871 128,111 128,126 144,801 143,126
Reference price 2 1.380 1.860 2.160 0.2150 0.3150 0.5900
Announcement Date 5/14/20 3/25/21 3/11/22 3/31/23 4/1/24 -
1CAD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 29.96 49.21 54.45 74.63 88.13 100.8
EBITDA 1 -16.66 -5.231 -9.056 4.113 21.2 23.71
EBIT 1 -18.2 -23.04 -20.48 -6.939 10.58 21.51
Operating Margin -60.76% -46.82% -37.62% -9.3% 12% 21.34%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow -30.15 -19.38 -48.56 - - -
FCF margin -100.64% -39.38% -89.19% - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/14/20 3/25/21 3/11/22 3/31/23 4/1/24 -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 13.37 13.66 15.64 21.09 18.85 19.04 19.09 20.2 24.68 24.17 24 24.9 25.6 26.3
EBITDA 1 -1.874 -4.434 -2.613 2.333 1.903 2.49 1.444 4.882 7.32 5.874 5.39 5.84 6.19 6.29
EBIT 1 -4.131 -7.99 -7.76 0.3082 -0.1892 0.7018 0.3685 -1.042 5.871 5.382 4.84 5.29 5.64 5.74
Operating Margin -30.9% -58.51% -49.62% 1.46% -1% 3.69% 1.93% -5.16% 23.8% 22.26% 20.17% 21.24% 22.03% 21.83%
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/10/21 3/11/22 5/11/22 8/11/22 11/14/22 3/31/23 5/15/23 8/14/23 11/14/23 4/1/24 - - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow -30.1 -19.4 -48.6 - - -
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 7.69 8.45 18 5.56 4.96 1
Capex / Sales 25.67% 17.17% 33.14% 7.45% 5.63% 0.99%
Announcement Date 5/14/20 3/25/21 3/11/22 3/31/23 4/1/24 -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. GDNS Stock
  4. Financials Goodness Growth Holdings, Inc.